Corneal confocal microscopy: A novel noninvasive means to diagnose neuropathy in patients with fabry disease

Muscle and Nerve

Volumn 40, Issue 6, 2009, Pages 976-984

  Tavakoli, Mitra ^a   Marshall, Andrew ^b   Thompson, Lorraine ^c   Kenny, Margaret ^c   Waldek, Stephen ^c   Efron, Nathan ^d   Malik, Rayaz A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Corneal confocal microscopy; Corneal nerves; Fabry disease; Neurodegeneration; Neuropathy small fibers

Indexed keywords

AGALSIDASE BETA;

ADULT; ARTICLE; CLINICAL ARTICLE; COLD SENSATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA; DISEASE SEVERITY; ELECTROPHYSIOLOGY; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; FUNCTIONAL ASSESSMENT; HETEROZYGOSITY; HUMAN; MALE; NERVE FIBER; NEUROLOGIC DISEASE; NEUROPATHY; NEUROPHYSIOLOGY; NOCICEPTION; PERONEUS NERVE; PRIORITY JOURNAL; SENSATION; VIBRATION SENSE;

ADULT; CORNEA; FABRY DISEASE; FEMALE; HUMANS; MALE; MICROSCOPY, CONFOCAL; PERONEAL NEUROPATHIES; SEVERITY OF ILLNESS INDEX;

EID: 71549116073     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21383     Document Type: Article

References (43)

1. Patel DV, McGhee CN. Mapping the corneal sub-basal nerve plexus in keratoconus by in vivo laser scanning confocal microscopy. Invest Ophthalmol Vis Sci 2006;47:1348-1351. (Pubitemid 46780740)
2. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med 1967;276:1163-1167.
3. Kint JA. Fabry's disease: alpha-galactosidase deficiency. Science 1970;167:1268-1269.
4. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001;38:750-760. (Pubitemid 33032930)
5. Ries M, Ramaswami U, Parini R, Lindblad B, Whybra C, Willers I, et al. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr 2003;162:767-772. (Pubitemid 37410024)
6. Hoffmann B, Beck M, Sunder-Plassmann G, Borsini W, Ricci R, Mehta A. Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy - a retrospective analysis from the Fabry Outcome Survey. Clin J Pain 2007;23:535-542. (Pubitemid 46956192)
7. Schiffmann R. Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapy. Acta Neurol Belg 2006;106:61-65. (Pubitemid 44044035)
8. Schiffmann R, Scott LJ. Pathophysiology and assessment of neuropathic pain in Fabry disease. Acta Paediatr 2002;91(suppl):48-52. (Pubitemid 36174150)
9. Hilz MJ, Stemper B, Kolodny EH. Lower limb cold exposure induces pain and prolonged small fiber dysfunction in Fabry patients. Pain 2000;84:361-365. (Pubitemid 30074239)
10. Kocen RS, Thomas PK. Peripheral nerve involvement in Fabry's disease. Arch Neurol 1970;22:81-88.
11. Luciano CA, Russell JW, Banerjee TK, Quirk JM, Scott LJ, Dambrosia JM, et al. Physiological characterization of neuropathy in Fabry's disease. Muscle Nerve 2002;26:622-629.
12. Dutsch M, Marthol H, Stemper B, Brys M, Haendl T, Hilz MJ. Small fiber dysfunction predominates in Fabry neuropathy. J Clin Neurophysiol 2002;19:575-586. (Pubitemid 36008382)
13. Syed NA, Sandbrink F, Luciano CA, Altarescu G, Weibel T, Schiffmann R, et al. Cutaneous silent periods in patients with Fabry disease. Muscle Nerve 2000;23:1179-1186. (Pubitemid 30602236)
14. Gomes I, Nora DB, Becker J, Ehlers JA, Schwartz IV, Giugliani R, et al. Nerve conduction studies, electromyography and sympathetic skin response in Fabry's disease. J Neurol Sci 2003;214:21-25. (Pubitemid 37100977)
15. Schiffmann R, Floeter MK, Dambrosia JM, Gupta S, Moore DF, Sharabi Y, et al. Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve 2003;28:703-710. (Pubitemid 37484832)
16. Moller AT, Feldt-Rasmussen U, Rasmussen AK, Sommer C, Hasholt L, Bach FW, et al. Small-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin. J Peripher Nerv Syst 2006;11:119-125. (Pubitemid 43894078)
17. Onishi A, Dyck PJ. Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch Neurol 1974;31:120-127.
18. Toyooka K, Said G. Nerve biopsy findings in hemizygous and heterozygous patients with Fabry's disease. J Neurol 1997;244:464-468. (Pubitemid 27379655)
19. Schiffmann R, Hauer P, Freeman B, Ries M, Scott LJ, Polydefkis M, et al. Enzyme replacement therapy and intraepidermal innervation density in Fabry disease. Muscle Nerve 2006;34:53-56.
20. Germain DP, Waldek S, Banikazemi M, Bushinsky DA, Charrow J, Desnick RJ, et al. Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease. J Am Soc Nephrol 2007;18:1547-1557. (Pubitemid 46717522)
21. Hughes DA, Elliott PM, Shah J, Zuckerman J, Coghlan G, Brookes J, et al. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart 2008;94:153-158. (Pubitemid 351211719)
22. Hilz MJ, Brys M, Marthol H, Stemper B, Dutsch M. Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy. Neurology 2004;62:1066-1072.
23. Kallinikos P, Berhanu M, O'Donnell C, Boulton AJ, Efron N, Malik RA. Corneal nerve tortuosity in diabetic patients with neuropathy. Invest Ophthalmol Vis Sci 2004;45:418-422. (Pubitemid 38140497)
24. Malik RA, Kallinikos P, Abbott CA, van Schie CH, Morgan P, Efron N, et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 2003;46:683-688. (Pubitemid 36808188)
25. Hossain P, Sachdev A, Malik RA. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet 2005;366:1340-1343. (Pubitemid 41443391)
26. Quattrini C, Tavakoli M, Jeziorska M, Kallinikos P, Tesfaye S, Finnigan J, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 2007;56:2148-2154. (Pubitemid 47195833)
27. Tavakoli M, Kallinikos PA, Efron N, Boulton AJ, Malik RA. Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes. Diabetes Care 2007;30:1895-1897. (Pubitemid 47036377)
28. Mehra S, Tavakoli M, Kallinikos PA, Efron N, Boulton AJ, Augustine T, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 2007;30:2608-2612. (Pubitemid 47547805)
29. Beck M. The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr 2006;95(suppl):43-46. (Pubitemid 43739094)
30. Kleinert J, Lorenz M, Hauser AC, Becherer A, Staudenherz A, Fodinger M, et al. Measurement of renal function in patients with Fabry disease. Acta Paediatr 2005;94(suppl):19-23. (Pubitemid 44617086)
31. Dyck PJ, Karnes J, O'Brien PC, Swanson CJ. Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology 1986;36:1300-1308. (Pubitemid 16008050)
32. Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ. Foot ulcer risk is lower in South-Asian and African-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study. Diabetes Care 2005;28:1869-1875.
33. Brookes NH, Loh IP, Clover GM, Poole CA, Sherwin T. Involvement of corneal nerves in the progression of keratoconus. Exp Eye Res 2003;77:515-524. (Pubitemid 37040849)
34. Simo Mannion L, Tromans C, O'Donnell C. An evaluation of corneal nerve morphology and function in moderate keratoconus. Cont Lens Anterior Eye 2005;28:185-192. (Pubitemid 43024700)
35. Benitez-Del-Castillo JM, Acosta MC, Wassfi MA, Diaz-Valle D, Gegundez JA, Fernandez C, et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci 2007;48:173-181. (Pubitemid 47251400)
36. Rosenberg ME, Tervo TM, Immonen IJ, Muller LJ, Gronhagen-Riska C, Vesaluoma MH. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci 2000;41:2915-2921. (Pubitemid 30691927)
37. Mastropasqua L, Nubile M, Lanzini M, Carpineto P, Toto L, Ciancaglini M. Corneal and conjunctival manifestations in Fabry disease: in vivo confocal microscopy study. Am J Ophthalmol 2006;141:709-718.
38. Mavrakanas N, Tajouri-Morizur N, Dosso AA. Corneal findings in Fabry disease-related keratopathy using in vivo confocal microscopy. J Fr Ophthalmol 2008;31:416-418.
39. Sodi A, Ioannidis AS, Mehta A, Davey C, Beck M, Pitz S. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey. Br J Ophthalmol 2007;91:210-214. (Pubitemid 46202871)
40. Falke K, Buttner A, Schittkowski M, Stachs O, Kraak R, Zhivov A, et al. The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study. Graefes Arch Clin Exp Ophthalmol 2009;247:523-534
41. Seiler KU, Thiel HJ, Wassermann O. Chloroquine keratopathy as an example of drug-induced phospholipidosis (contribution to the pathogenesis of cornea verticillata) [author's transl]. Klin Monatsbl Augenheilkd 1977;170:64-73.
42. Hirano K, Murata K, Miyagawa A, Terasaki H, Saigusa J, Nagasaka T, et al. Histopathologic findings of cornea verticillata in a woman heterozygous for Fabry's disease. Cornea 2001;20:233-236. (Pubitemid 32174103)
43. Macrae WG, Ghosh M, McCulloch C. Corneal changes in Fabry's disease: a clinico-pathologic case report of a heterozygote. Ophthal Paediatr Genet 1985;5:185-190. (Pubitemid 15094857)